Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.

About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/237132
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/237132
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

GABRIEL PARDO

Listed Specialty: Neurology
820 NE 15TH ST, OKLAHOMA CITY, OK, 73104-4602

2018 Payments: At a Glance

233

payments

$190,865

payment total

18

companies paid this doctor

Types of Payments

Category Payments Payment Value
Consulting
 11 $85,135
Promotional Speaking/Other
 29 $84,500
Travel and Lodging
 40 $14,510
Food and Beverage
 150 $6,607
Education
 3 $114

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
OCREVUS

drug

 $44,461
LEMTRADA

drug

 $44,001
Payments with no listed product

N/A

 $26,280
AUBAGIO

drug

 $23,391
GILENYA

drug

 $19,158
TYSABRI

drug

 $13,853
TECFIDERA

drug

 $13,703
ZINBRYTA

drug

 $13,568
MAVENCLAD

drug

 $10,216
REBIF

drug

 $8,810
OMB157B

drug

 $6,982
OZANIMOD

drug

 $6,486
ACTHAR

drug

 $343
COPAXONE

drug

 $177
MS DISEASE STATE

drug

 $113
RITUXAN

drug

 $76
AIMOVIG

drug

 $72
BOTOX

drug

 $34
BETASERON

drug

 $25
DYSPORT

drug

 $17
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

For ease of printing, only the 20 drugs and devices with the highest payments are displayed. For a complete list, please visit: https://projects.propublica.org/docdollars/doctors/pid/237132

Payment Details

When How Much Related To What For From Third Party Payee
Aug 10, 2018 $15,435 LEMTRADA Consulting GENZYME CORPORATION
Mar 29, 2018 $12,611 LEMTRADA AUBAGIO Consulting GENZYME CORPORATION
Jan 6, 2018 $12,113 TYSABRI TECFIDERA ZINBRYTA Consulting BIOGEN, INC.
Nov 10, 2018 $9,450 No Listed Product Consulting BIOGEN, INC.
Aug 14, 2018 $9,020 MAVENCLAD Consulting EMD SERONO, INC.
Sep 11, 2018 $6,466 OMB157B Consulting NOVARTIS PHARMA AG
Nov 9, 2018 $6,290 OZANIMOD Consulting CELGENE CORPORATION
Nov 29, 2018 $4,800 OCREVUS Promotional Speaking/Other GENENTECH USA, INC.
Nov 28, 2018 $4,800 OCREVUS Promotional Speaking/Other GENENTECH USA, INC.
Feb 15, 2018 $4,800 OCREVUS Promotional Speaking/Other GENENTECH USA, INC.
Jun 9, 2018 $4,500 OCREVUS Consulting GENENTECH USA, INC.
Oct 8, 2018 $4,500 OCREVUS Consulting GENENTECH USA, INC.
Oct 30, 2018 $3,880 AUBAGIO Promotional Speaking/Other GENZYME CORPORATION
Jan 5, 2018 $3,800 No Listed Product Consulting BIOGEN, INC.
Jul 25, 2018 $3,192 GILENYA Promotional Speaking/Other NOVARTIS PHARMACEUTICALS CORPORATION
Mar 16, 2018 $3,192 GILENYA Promotional Speaking/Other NOVARTIS PHARMACEUTICALS CORPORATION
Apr 9, 2018 $3,192 GILENYA Promotional Speaking/Other NOVARTIS PHARMACEUTICALS CORPORATION
Feb 8, 2018 $3,153 LEMTRADA Promotional Speaking/Other GENZYME CORPORATION
Sep 6, 2018 $3,000 OCREVUS Promotional Speaking/Other GENENTECH USA, INC.
Apr 18, 2018 $3,000 OCREVUS Promotional Speaking/Other GENENTECH USA, INC.

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/237132

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.